Skip to content

Interaction Research on Cognitive Impairment and Emotional Disorder in End-stage Renal Disease

Interaction Research on Cognitive Impairment and Emotional Disorder in End-stage Renal Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03191409
Enrollment
50
Registered
2017-06-19
Start date
2017-06-15
Completion date
2019-06-30
Last updated
2017-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Damage, End-stage Kidney Disease

Keywords

cognitive impairment, ESRD, functional MRI

Brief summary

End stage renal disease (ESRD) is the last stage (stage 5) of chronic kidney disease (CKD). Abnormalities of cognitive function and high levels of depression or anxiety incidence are characteristic of hemodialysis patients. In this research project, the investigators subject in ESRD patients starting hemodialysis as the carrier. Based on the longitudinal research design, using multimodal neuroimaging data,combining with the interact relationship between changes of brain morphology, the dysfunction of resting-state and-task state with cognitive impairment and abnormal emotions.Establish brain structure-function change model associated with dialysis progression, Explore imaging markers of central and disease development characteristics in ESRD patients. the investigators attempt to clarify the core mechanism of kidney-brain axis damage, thus provide evidence for early cognitive-behavioral therapy to CKD patient.

Interventions

None listed

Sponsors

Xidian University
CollaboratorOTHER
First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age 18-50 years; 2. ESRD patients who will start hemodialysis 3. High quality MRI scan; 4. dextromanual

Exclusion criteria

1. Diabetes,Brain tumor,brain trauma 2. Neuropsychiatric disease

Design outcomes

Primary

MeasureTime frameDescription
change in cognitive functionChange from Baseline to 3 Months after dialysisCognitive testing will be performed for assessment

Secondary

MeasureTime frameDescription
Change in brain MRIChange from Baseline to 3 Months after dialysisBrain MRI will be performed before dialysis initiation and dialysis more than 3 months

Countries

China

Contacts

Primary ContactMing Zhang, Ph.D
zmmri@163.com18991232265

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026